The Intersecting Future: How Telehealth and Brick-and-Mortar Care Models Are Converging

By Shannon Smith, DNP, APRN, FNP-C, PMHNP-BC, PMHNP-C · 2026-04-17

The COVID-19 pandemic accelerated telehealth adoption, but the future of healthcare isn't purely virtual. We're witnessing a strategic convergence of telehealth and traditional brick-and-mortar care, creating hybrid models that demand sophisticated compliance strategies. This article explores the regulatory and operational implications for healthcare leaders navigating this evolving landscape.

The seismic shift in healthcare delivery brought about by the COVID-19 pandemic irrevocably altered patient expectations and provider capabilities. While telehealth emerged as a critical lifeline, the narrative is now evolving beyond a simple 'virtual vs. in-person' dichotomy. We are witnessing a sophisticated convergence of telehealth and brick-and-mortar care models, creating hybrid ecosystems that promise enhanced access, efficiency, and patient outcomes. For healthcare leaders – from telehealth founders to established practice owners – understanding this strategic intersection is paramount to future-proofing operations and ensuring sustained compliance.

> For more on this topic, see our analysis: [The Looming Shift: How Telehealth's 'Legitimate Medical Purpose' Will Redefine Care Delivery](/blog/telehealth-legitimate-medical-purpose).

This isn't merely about offering both options; it's about seamlessly integrating them to optimize the patient journey and provider workflow. Consider the patient who begins their care journey with a virtual consultation, transitions to an in-person diagnostic test, and then manages their chronic condition through remote monitoring and periodic telehealth follow-ups. This integrated approach, while offering immense potential, introduces a complex web of regulatory challenges that demand proactive and robust compliance frameworks.

> For more on this topic, see our analysis: [The GLP-1 Gold Rush: Navigating the Regulatory Minefield in Telehealth Weight Loss](/blog/glp1-telehealth-regulatory-minefield-mo2iasvx).

The Driving Forces Behind Convergence

Several factors are propelling this convergence:

Patient Preference & Convenience: Post-pandemic, patients expect flexibility. A 2023 McKinsey report indicated that 75% of consumers who used telehealth during the pandemic plan to use it again, but also value in-person care for specific needs. The convenience of virtual visits for routine follow-ups or initial screenings, combined with the necessity of hands-on care for diagnostics, procedures, and complex conditions, drives demand for hybrid models.
Provider Efficiency & Resource Optimization: Telehealth can alleviate the burden on physical clinics, reduce wait times, and allow providers to manage a larger patient panel. This is particularly critical in addressing physician shortages and improving access in underserved areas. By offloading routine tasks to virtual platforms, brick-and-mortar facilities can focus on higher-acuity or procedure-based care.
Reimbursement Stability & Expansion: While some pandemic-era flexibilities have expired, the Centers for Medicare & Medicaid Services (CMS) has continued to expand the list of services eligible for Medicare reimbursement via telehealth, broadening provider eligibility. As highlighted in "CMS Expands Telehealth Services and Provider Eligibility Under Medicare" (Recent Intelligence #10), this signals a sustained commitment to integrating telehealth into the permanent healthcare landscape. This evolving reimbursement environment provides a financial incentive for practices to build sustainable hybrid models.
Technological Advancements: Innovations in remote patient monitoring (RPM), wearable health devices, and AI-powered diagnostics are enabling more comprehensive virtual care, blurring the lines between what can be done remotely and what requires an in-person visit. These technologies facilitate data exchange and continuous patient engagement, making integrated care more feasible.

Navigating the Regulatory Labyrinth of Hybrid Care

The convergence of care models, while beneficial, significantly amplifies compliance complexities. Healthcare leaders must contend with a multifaceted regulatory environment that touches upon licensure, scope of practice, corporate practice of medicine (CPOM), prescribing controlled substances, and fraud enforcement.

1. Licensure and Interstate Practice: The Foundation of Hybrid Care

For any hybrid model to thrive, providers must be appropriately licensed in the state where the patient is located, regardless of whether the encounter is virtual or in-person. This fundamental principle remains a cornerstone of healthcare regulation. As practices expand their reach through telehealth, they inevitably encounter interstate licensing challenges.

Consider a practice based in Michigan (as per "Michigan Medical Board Enforcement Trends" - Recent Intelligence #1) that wishes to offer virtual follow-ups to patients who may reside in Ohio. The Michigan-licensed provider must also hold an Ohio license to conduct that telehealth visit, even if the initial in-person visit occurred in Michigan. This necessitates robust credentialing processes to track and manage multi-state licenses for all practitioners.

2. Corporate Practice of Medicine (CPOM) in a Hybrid World

The Corporate Practice of Medicine doctrine, which prohibits corporations from employing physicians or controlling medical decision-making, presents a significant hurdle for innovative hybrid models, especially those involving non-clinical investors or management entities. States like Iowa and Kentucky (as detailed in "Iowa's Strict Corporate Practice of Medicine Doctrine" - Recent Intelligence #7 and "Kentucky's Corporate Practice of Medicine Doctrine" - Recent Intelligence #3) maintain stringent CPOM enforcement.

For a telehealth brand seeking to partner with a local brick-and-mortar clinic to offer integrated services, the structure must meticulously separate clinical and administrative functions. A Management Service Organization (MSO) model is often employed, where the corporate entity provides non-clinical services (e.g., technology, billing, marketing) to an independently owned professional medical corporation. The MSO cannot dictate clinical decisions, employ licensed professionals who render medical services, or engage in fee-splitting. The financial relationship must be at fair market value for administrative services, independent of patient volume or medical services rendered. Failure to adhere to CPOM can lead to severe penalties, including license revocation and corporate dissolution, as seen with the increased scrutiny on DTC telehealth brands (as noted in "Navigating Corporate Practice of Medicine Restrictions for DTC Telehealth Weight Loss Brands" - Recent Intelligence #8).

3. Prescribing Controlled Substances: A High-Stakes Compliance Area

The prescribing of controlled substances via telehealth is arguably the most scrutinized area of virtual care, and its integration into hybrid models demands extreme caution. The DEA's proposed rules, following the expiration of COVID-19 PHE waivers, emphasize the requirement for an in-person medical evaluation for initial prescriptions of Schedule II and certain Schedule III-V controlled substances, with specific exceptions for buprenorphine (as per "DEA Proposes New Telehealth Prescribing Rules" - Recent Intelligence #2). This means that a purely virtual model for initiating controlled substance prescriptions is increasingly untenable.

For hybrid practices, this often translates to a workflow where:

An initial in-person evaluation at the brick-and-mortar facility establishes the legitimate medical purpose for a controlled substance prescription.
Subsequent follow-ups and prescription renewals may occur via telehealth, provided the initial in-person visit requirement was met and state-specific regulations allow for it.
For buprenorphine, temporary PHE flexibilities are extended, but practices must prepare for eventual stricter requirements, potentially including an initial in-person visit or referral from a practitioner who has conducted one.

The Department of Justice (DOJ) has intensified enforcement against telehealth companies involved in illegal prescribing ("DOJ Intensifies Enforcement Against Telehealth Controlled Substance Prescribing Violations" - Recent Intelligence #4). This underscores that even with a hybrid model, the 'legitimate medical purpose' standard is paramount. Practices must have robust protocols for patient intake, provider training, and technological safeguards to ensure every controlled substance prescription is preceded by a comprehensive, individualized medical evaluation. This includes meticulous record-keeping and clear processes for handling red flags related to potential drug-seeking behavior. DEA registration across state lines also adds another layer of complexity for multi-state hybrid models (as discussed in "Navigating DEA Registration for Telehealth Providers Prescribing Controlled Substances Across State Lines" - Recent Intelligence #5).

4. Establishing the Provider-Patient Relationship: State-Specific Nuances

The method for establishing a valid provider-patient relationship via telehealth varies significantly by state. Some states, like the District of Columbia, explicitly require a real-time, interactive audio-visual examination for initial consultations, particularly for prescribing (as highlighted in "District of Columbia Telehealth" - Recent Intelligence #9). This directly impacts hybrid models that might consider asynchronous or audio-only modalities for initial patient intake.

For a hybrid practice, this means:

Initial Engagement: While a patient might discover the practice online and complete initial paperwork virtually, the first clinical encounter for establishing a relationship (especially for prescribing or complex diagnoses) may need to be a synchronous audio-visual telehealth visit or an in-person visit, depending on state law and the specific service.
Follow-Up Flexibility: Once a relationship is established, many states allow for greater flexibility in follow-up care, including asynchronous messaging or audio-only calls, provided they align with the standard of care.

Practices must ensure their technology platforms and clinical protocols are agile enough to adapt to these state-specific requirements, prioritizing compliance over a one-size-fits-all approach.

5. Scope of Practice and Supervision in Specialized Fields

Medspas, dental practices, and chiropractic offices are increasingly integrating telehealth for consultations, follow-ups, and remote patient management. However, their unique scopes of practice introduce specific compliance considerations within a hybrid framework.

Medspas: Any service requiring a medical license (e.g., injectables, laser treatments) must be performed under the direct supervision or delegation of a licensed physician, APRN, or PA. A hybrid medspa might offer virtual consultations for treatment planning or post-procedure checks, but the actual medical procedure requires an in-person visit and appropriate supervision. The Michigan Board of Medicine's scrutiny of medspa operations ("Michigan Medical Board Enforcement Trends" - Recent Intelligence #1) underscores the need for clear delineation of services and active medical director engagement.
Dental Practices: Teledentistry can facilitate pre-consultations, post-operative checks, and oral health education. However, diagnostic procedures requiring X-rays or hands-on examinations necessitate an in-person visit. The hybrid model allows for efficient triage and follow-up, freeing up chair time for necessary procedures.
Chiropractic Care: State chiropractic boards are issuing guidance on telehealth for initial consultations, follow-up visits, and remote patient management ("Navigating Telehealth for Chiropractic Care" - Recent Intelligence #6). While some aspects of RPM (e.g., exercise adherence monitoring) can be done remotely, the definition of a 'physical examination' and its requirements for establishing a patient-provider relationship remain critical. Hybrid models can leverage telehealth for initial screenings or progress checks, but hands-on adjustments and certain diagnostic procedures require in-person care.

The Role of TrueEval in Enabling Hybrid Care Compliance

The strategic convergence of telehealth and brick-and-mortar care models is not just a trend; it's the future of healthcare delivery. However, this future is inextricably linked to robust, dynamic compliance. This is where TrueEval becomes indispensable.

TrueEval provides the essential infrastructure for healthcare organizations to navigate this complex, evolving regulatory landscape. Our platform enables:

Multi-State Licensure Management: Centralized tracking and verification of provider licenses across all relevant states, ensuring compliance for both virtual and in-person care components.
Dynamic Regulatory Intelligence: Real-time updates on state-specific telehealth laws, CPOM doctrines, and prescribing regulations (including DEA guidance), allowing practices to adapt their hybrid models proactively.
Automated Compliance Workflows: Tools to ensure proper establishment of provider-patient relationships (e.g., verifying audio-visual requirements), documentation standards, and consent processes for integrated care.
Risk Mitigation for Controlled Substances: Features to help practices implement and monitor protocols for controlled substance prescribing, aligning with federal and state requirements for in-person evaluations and legitimate medical purpose.
Scope of Practice Verification: Ensuring that all services, whether virtual or in-person, are delivered within the legal scope of practice for each licensed professional and specialty.

By leveraging TrueEval, healthcare leaders can confidently build and scale integrated care models, knowing their operations are grounded in a robust and adaptable compliance framework. This allows them to focus on delivering high-quality, accessible patient care without being overwhelmed by regulatory complexities.

What This Means For Your Practice

The future of healthcare is undeniably hybrid. For telehealth founders, this means strategically partnering with or developing brick-and-mortar touchpoints to offer comprehensive care, especially for services requiring in-person components like diagnostics or controlled substance initiation. For brick-and-mortar practice owners, it means embracing telehealth not as a separate offering, but as an integrated extension of your existing services, enhancing patient access and operational efficiency.

Actionable Implications:

1. Conduct a Regulatory Gap Analysis: Assess your current operational model against the evolving landscape of state and federal telehealth, CPOM, and controlled substance regulations. Identify areas where your hybrid approach might create compliance vulnerabilities. 2. Invest in Compliance Infrastructure: Manual compliance is unsustainable in a hybrid environment. Implement technology solutions like TrueEval to automate licensure tracking, policy management, and regulatory updates. 3. Standardize Integrated Workflows: Develop clear protocols for patient intake, virtual-to-in-person transitions, and documentation that satisfy both telehealth and traditional care requirements. Ensure consistent application across all modalities. 4. Prioritize Provider Training: Educate your clinical and administrative staff on the nuances of hybrid care compliance, including state-specific rules for establishing patient relationships and prescribing. 5. Seek Expert Legal Counsel: Engage attorneys specializing in healthcare regulatory law to review your MSO agreements, partnership structures, and prescribing policies, especially when operating across state lines or dealing with CPOM-strict jurisdictions.

Embracing the convergence of telehealth and brick-and-mortar care is not just about staying competitive; it's about building a more resilient, accessible, and patient-centric healthcare system. With a proactive and robust compliance strategy, your practice can lead this transformation, delivering seamless care that meets both patient needs and regulatory demands.